knowledge -WSS

knowledge

author：explore 2025-09-28 00:52:52 - browse：1

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Wikipedia

WSS

Peter Marks talks Operation Warp Speed for Rare Diseases

Medical school prerequisites are outdated

FDA reorg will put new emphasis on investigations, sources say

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Humana CEO Bruce Broussard to step down in 2024

Humana CEO Bruce Broussard to step down in 2024

leisure time

knowledge

Wikipedia

Supreme Court strikes down use of affirmative action

Today's health inequities arise from racist U.S. history, say experts

How one medical school became remarkably diverse

Study suggests Covid rebound is far more common with Paxlovid than without

Walensky prepares to leave CDC — and Congress — behind

White House drug czar issues call for 'recovery

Medicare proposal to cover medical devices draws a mixed reaction

Medicare’s new pay boost for primary care is angering specialists

Jerome Adams on the need for new antivirals for Covid

Publishing genetic code of viruses could cause disaster

focus

Weight loss drugs should be covered by insurers, AMA says

There’s no way to know how good AI health technologies are

Ohio still needs to do more to protect the right to abortion

Experimental asthma app from Apple and Anthem shows promise

Ohio still needs to do more to protect the right to abortion

CVS, Rite Aid closures threaten to worsen pharmacy deserts

focus

Wikipedia

hotspot

focus